Speed, baby, speed: The Digest’s 2017 Multi-Slide Guide to DMC

November 22, 2017 |

DMC’s technology enables reproducibility and robustness to scale; Production of a diversity of targets using a single bioprocess; HTS approaches that translate to full scale performance — and the company says, “50X improvement in speed and cost of product development.” The business model? Specialty chemicals, nutrition products, and pharmaceuticals, with a focus on partner agreements to quickly generate revenue and validate the technology; eventually, commercialization through strategic partnerships and existing supply chains.

DMC CEO Matt Lipscomb gave this illuminating update on the technology’s promise and progress at ABLC Next 2017 in San Francisco.

Prev1 of 13
Use your ← → (arrow) keys to browse

Tags:

Category: 8-Slide Guide

Comments are closed.